A combination therapy of the ATRi ceralasertib and radiation decreased the number of tumour-infiltrating Tregs in mouse models of KRAS-mutant cancer [33], as well as in a mouse model of hepatocellular carcinoma [34]. The gene discussed is KRAS; the disease is cancer.